Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1977 2
1978 1
1981 1
1982 2
1983 4
1984 1
1985 4
1986 1
1987 4
1988 4
1989 1
1990 6
1991 4
1992 9
1993 9
1994 4
1995 3
1996 3
1997 6
1998 5
1999 12
2000 16
2001 13
2002 16
2003 24
2004 19
2005 24
2006 40
2007 44
2008 45
2009 42
2010 43
2011 46
2012 58
2013 51
2014 44
2015 43
2016 41
2017 43
2018 45
2019 34
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

738 results
Results by year
Filters applied: . Clear all
Page 1
Topical agents and dressings for fungating wounds.
Adderley UJ, Holt IG. Adderley UJ, et al. Cochrane Database Syst Rev. 2014 May 15;2014(5):CD003948. doi: 10.1002/14651858.CD003948.pub3. Cochrane Database Syst Rev. 2014. PMID: 24832784 Free PMC article. Review.
Does pelvic mesh treated with phosphorylcholine improve outcomes? An early experience.
Chakrabarty A, Ganabathi K, Alexander JS, Hoekstra P, Martin J Jr, Zylstra S. Chakrabarty A, et al. Eur J Obstet Gynecol Reprod Biol. 2013 Apr;167(2):230-4. doi: 10.1016/j.ejogrb.2012.11.015. Epub 2012 Dec 29. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 23280282 Clinical Trial.
Interventions to treat cutaneous leishmaniasis in children: A systematic review.
Uribe-Restrepo A, Cossio A, Desai MM, Dávalos D, Castro MDM. Uribe-Restrepo A, et al. PLoS Negl Trop Dis. 2018 Dec 14;12(12):e0006986. doi: 10.1371/journal.pntd.0006986. eCollection 2018 Dec. PLoS Negl Trop Dis. 2018. PMID: 30550538 Free PMC article.
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.
Kaley TJ, Panageas KS, Mellinghoff IK, Nolan C, Gavrilovic IT, DeAngelis LM, Abrey LE, Holland EC, Lassman AB. Kaley TJ, et al. J Neurooncol. 2019 Sep;144(2):403-407. doi: 10.1007/s11060-019-03243-7. Epub 2019 Jul 19. J Neurooncol. 2019. PMID: 31325145 Clinical Trial.
Visceral Leishmaniasis-Optimum Treatment Options in Children.
Sundar S, Agarwal D. Sundar S, et al. Pediatr Infect Dis J. 2018 May;37(5):492-494. doi: 10.1097/INF.0000000000001885. Pediatr Infect Dis J. 2018. PMID: 29280784 Free PMC article. Review.
High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.
Fernandez-Prada C, Sharma M, Plourde M, Bresson E, Roy G, Leprohon P, Ouellette M. Fernandez-Prada C, et al. Int J Parasitol Drugs Drug Resist. 2018 Aug;8(2):165-173. doi: 10.1016/j.ijpddr.2018.03.004. Epub 2018 Mar 16. Int J Parasitol Drugs Drug Resist. 2018. PMID: 29602064 Free PMC article.
A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis.
Carnielli JBT, Crouch K, Forrester S, Silva VC, Carvalho SFG, Damasceno JD, Brown E, Dickens NJ, Costa DL, Costa CHN, Dietze R, Jeffares DC, Mottram JC. Carnielli JBT, et al. EBioMedicine. 2018 Oct;36:83-91. doi: 10.1016/j.ebiom.2018.09.029. Epub 2018 Sep 27. EBioMedicine. 2018. PMID: 30268832 Free PMC article.
738 results
Jump to page
Feedback